Akebia Therapeutics AKBA Hovers Near Critical Support as Downside Momentum Persists Investors Shift Focus to SmallCap US Tech Stocks for AI Growth Opportunities GPRE Q1 2026 Earnings Massive EPS Beat Despite Revenue Uncertainty EU Seeks to Deepen US Talks on Advanced AI Cyber Models Amid Anthropic Mythos Concerns